Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
Australia
Macquarie University, Sydney, New South Wales Blacktown Hospital, Sydney, New South Wales Sunshine Coast University Private Hospital, Birtinya, Queensland Cancer Research SA, Adelaide, South Australia